Inventurus Knowledge Solutions Limited — PPTs, 15-05-2025: Investor Presentation

1. Financial Highlights:

IKS Health reported Q4 revenue of ₹724 Cr, up 17% YoY (13% in USD), with EBITDA margin expanding to 31.2% and PAT margin at 20.4%. FY25 revenue rose 47% YoY to ₹2,664 Cr, with steady EBITDA margins around 30% and PAT margin of 18.2%. Adjusted PAT increased 39%, despite a 54% rise in employee costs from workforce growth to 12,661 employees (2,294 clinically trained). Return on equity surged to 29%, and earnings per share grew 31%. Operating and free cash flows improved, supporting growth investments.

2. Strategic Initiatives & Growth Drivers:

IKS is advancing tech-driven healthcare services by integrating AI throughout the patient journey—from pre-visit to billing and care management. The company is expanding its clinical and tech workforce, now with 473 tech employees and 49% women staff. Enhanced AI capabilities aim to boost revenue cycle management and patient engagement. Long-standing client relationships (6+ years for top 10 clients) provide steady revenue, while automation and digital investments position IKS to capture a share of a ~$280B healthcare outsourcing market.

3. Business Developments:

IKS secured several large platform deals, strengthening ties with clients like OrthoNY, GI Alliance, Sky Lakes, Western Washington Medical Group, and Platinum Dermatology Partners. These partnerships leverage the IKS care enablement platform to optimize clinical and financial functions. The company earned top rankings in Clinical Documentation (12th consecutive year) and AI-driven Revenue Cycle Management (Black Book Research 2025), enhancing brand trust.

4. Market Position & Competitive Advantage:

IKS leads with a unique end-to-end platform covering the full patient journey, backed by high client retention (90%+) and deep domain expertise. Accolades in clinical documentation, medical coding, and AI-enhanced RCM highlight its differentiation. Its scale, multi-skilled workforce, and durable client partnerships create strong moats in a fragmented healthcare outsourcing sector.

5. Investor Implications:

Strong revenue growth combined with margin expansion indicates positive growth potential. High client loyalty and expanding partnerships reduce execution risks. Improving cash flows and return on equity support a healthy financial profile. Continued investments in AI and workforce scaling are key to sustaining leadership in a large, evolving healthcare market.